There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Advancing Access to Precision Medicine Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To provide for a study by the National Academy of Medicine on the use of genetic and genomic testing to improve health care, and for other purposes.


Actions Overview (1)

Date
02/15/2018Introduced in House

All Actions (3)

Date
02/16/2018Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
02/15/2018Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
02/15/2018Introduced in House
Action By: House of Representatives

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce02/15/2018 Referred to
House Energy and Commerce Subcommittee on Health02/16/2018 Referred to

No related bill information was received for H.R.5062.


Subjects (1)


Latest Summary (1)

There is one summary for H.R.5062. View summaries

Shown Here:
Introduced in House (02/15/2018)

Advancing Access to Precision Medicine Act

This bill requires the Department of Health and Human Services to enter into an arrangement with the National Academy of Medicine for the academy to study usage of genetic and genomic testing, including how to reduce barriers to the utilization of such testing.

The bill allows states to apply for an exception to Medicaid's federal medical assistance percentage rate to provide whole genome sequencing clinical services to certain children, including those admitted to a pediatric intensive care unit for a chronic or undiagnosed disease and those suspected to have a pediatric-onset genetic disease.